Related Experiment Videos
Breast cancer and pregnancy
Y T Chang1, C C Loong, H C Wang
1Department of Surgery, Veterans General Hospital-Taipei, Taiwan, R.O.C.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|October 1, 1994
Summary
Pregnancy-associated breast cancer (PABC) shows similar survival rates to non-pregnant cases. Early diagnosis and aggressive management remain crucial for improving treatment outcomes in pregnant women with breast cancer.
Area of Science:
- Oncology
- Reproductive Medicine
- Public Health
Background:
- Pregnancy-associated breast cancer (PABC) is rare, posing diagnostic and therapeutic challenges.
- Limited data exists on PABC, particularly in Taiwan.
- This review aims to enhance understanding and treatment of PABC.
Purpose of the Study:
- To compare the clinical characteristics and outcomes of PABC with non-pregnant breast cancer patients.
- To identify factors influencing survival in PABC.
Main Methods:
- Retrospective analysis of 21 pregnant or postpartum women diagnosed with breast cancer between 1979-1988.
- Comparison with 199 non-pregnant breast cancer patients treated during the same period.
- Follow-up until December 1990.
Main Results:
- No significant difference in overall 5-year survival rates between pregnant (57.1%) and non-pregnant (69.6%) groups.
- Significantly longer diagnostic time lag in the pregnant group.
- Equivalent survival rates at most stages, with a non-significant trend towards lower survival in pregnant patients at Stage II.
Conclusions:
- Early diagnosis and aggressive management are key principles for treating breast cancer in pregnant women.
- PABC outcomes are comparable to non-pregnant cases when managed appropriately.
- Further research is needed to optimize PABC treatment strategies.